)
Pioneer in iron-based therapies, CSL Vifor is a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, when pharmacist Caspar Friedrich Hausmann opened a pharmacy in St. Gallen, Switzerland. Since then, we have proven our ability to identify and serve therapeutic areas and patients with significant unmet medical need.
Building on our heritage and expertise in iron deficiency therapy, and together with our joint company Vifor Fresenius Medical Care Renal Pharma, today we have a strong and rapidly growing presence in nephrology, and we are committed to launching the next generation of therapies to truly address the full spectrum of kidney disease.
With our iron deficiency and iron deficiency anaemia expertise in heart failure, kidney disease, gastroenterology and inflammatory bowel disease, patient blood management and woman’s health, we help patients affected by these conditions to live better, healthier lives.
We partner with specialists to improve the lives of patients with high unmet medical needs across all stages of kidney disease. Through our broad portfolio we aim to preserve renal function, manage complications and improve quality of life.
With a presence in over 100 countries across the world, we are a global partner of choice for pharmaceuticals and innovative, leading therapies in iron deficiency and nephrology. We specialize in strategic global partnering, in-licensing and developing, manufacturing and marketing pharmaceutical products for precision healthcare, aiming to help patients around the world lead better, healthier lives.
